We present a microfluidic tilting platform with gravity-driven flow that enables culturing of three-dimensional microtissues under in vivo-like drug dosing regimens. In contrast to traditional, constant dosing regimens, the chip allows for gradual changes in substance concentrations. Dosing gradients are generated through an asymmetric Y-junction of microfluidic channels of different widths. Changes in the chip operation parameters, e.g., different tilting angles, enable to alter the drug dosage on demand. The concentration changes over time matched the predicted values, and preformed microtissues could be cultured in the chip system for at least 24 h. The chip represents an easy-to-handle tool for toxicity and efficacy testing of transient...
The ability to generate chemical and mechanical gradients on chips is important both for creating bi...
A microfluidic chip featuring laminar flow-based parallel gradient-generating networks was designeda...
Although the process of drug development requires efficacy and toxicity testing in animals prior to ...
We present a microfluidic tilting platform with gravity-driven flow that enables culturing of three-...
In vitro screening methods for compound efficacy and toxicity to date mostly include cell or tissue ...
In vitro screening methods for compound efficacy and toxicity to date mostly include cell or tissue ...
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like concentration pro...
Human response to drugs and environmental chemicals is often dramatically different from predictions...
Enabling the high-throughput biological assays requires a favorable biomimetic environment with appr...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
We present a 3-D microfluidic device designed for localized drug delivery to cellular networks. The ...
Test compounds used on in vitro model systems are conventionally delivered to cell culture wells as ...
We describe a microfuidic cell culture platform for real-time measurement of drug concentrations dur...
We report on a free-standing microfluidic pipette made in poly(dimethylsiloxane) having a circulatin...
The process of developing and testing drug candidates is a slow and costly endeavor. The mainstream ...
The ability to generate chemical and mechanical gradients on chips is important both for creating bi...
A microfluidic chip featuring laminar flow-based parallel gradient-generating networks was designeda...
Although the process of drug development requires efficacy and toxicity testing in animals prior to ...
We present a microfluidic tilting platform with gravity-driven flow that enables culturing of three-...
In vitro screening methods for compound efficacy and toxicity to date mostly include cell or tissue ...
In vitro screening methods for compound efficacy and toxicity to date mostly include cell or tissue ...
We present a microfluidic device to expose cancer cells to a dynamic, in vivo-like concentration pro...
Human response to drugs and environmental chemicals is often dramatically different from predictions...
Enabling the high-throughput biological assays requires a favorable biomimetic environment with appr...
Microfluidic devices present unique advantages for the development of efficient drug carrier particl...
We present a 3-D microfluidic device designed for localized drug delivery to cellular networks. The ...
Test compounds used on in vitro model systems are conventionally delivered to cell culture wells as ...
We describe a microfuidic cell culture platform for real-time measurement of drug concentrations dur...
We report on a free-standing microfluidic pipette made in poly(dimethylsiloxane) having a circulatin...
The process of developing and testing drug candidates is a slow and costly endeavor. The mainstream ...
The ability to generate chemical and mechanical gradients on chips is important both for creating bi...
A microfluidic chip featuring laminar flow-based parallel gradient-generating networks was designeda...
Although the process of drug development requires efficacy and toxicity testing in animals prior to ...